Nexalis Therapeutics Ltd NX1.AX
AUD0.01
Last Updated: Jul 23, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
Nexalis Therapeutics Ltd. Stock Analysis NX1.AX
Australia Health Care Nano Cap Nexalis Therapeutics Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing onset, inhaled therapies to address unmet medical needs in the pain management and mental health sectors. The firm is focused on the development of IRX-211 to treat Breakthrough Cancer Pain (BTcP), and IRX-616a to treat panic disorders (PD) and SRX-25 for the treatment of Treatment-Resistant Depression (TRD). The firm operates through segment development of medicinal drug-device products to address unmet medical needs. Its IRX-211 focuses on the management of BTcP with non-opioid, onset inhaled therapy. The Phase I clinical trials for IRX-211 have been completed. Its IRX-616a is an approved inhaled medication for panic disorder, offering a novel treatment avenue.
Nexalis Therapeutics Ltd (NX1.AX) Chart
Financial Metrics & Statements of Nexalis Therapeutics Ltd (NX1.AX)
FAQ's for Nexalis Therapeutics Ltd (NX1.AX)
- As of August 2026, Nexalis Therapeutics Ltd NX1.AX is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nexalis Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nexalis Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nexalis Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nexalis Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nexalis Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Nexalis Therapeutics Ltd (NX1.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
